Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Torrisi, R."'
Autor:
Baglietto, L., Torrisi, R., Arena, G., Francesca Tosetti, Gonzaga, A. G., Pasquetti, W., Robertson, C., Decensi, A.
Publikováno v:
Web of Science
Scopus-Elsevier
Scopus-Elsevier
Fenretinide is a vitamin A derivative under investigation in cancer prevention trials. Because all available pharmacologic and toxicologic data were obtained from breast cancer patients, we measured plasma drug, metabolite, and vitamin A levels and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c85ae912bd3921018d5bd37ded0f4497
https://publons.com/publon/3631118/
https://publons.com/publon/3631118/
Autor:
Decensi, A., Torrisi, R., Bruno, S., Massimo Costantini, Curotto, A., Nicolo, G., Malcangi, B., Baglietto, L., Bruttini, G. P., Gatteschi, B., Rondanina, G., Varaldo, M., Perloff, M., Malone, W. F., Bruzzi, P.
Publikováno v:
Web of Science
Scopus-Elsevier
Scopus-Elsevier
Retinoids have shown a potential activity in preventing tumor recurrence in superficial bladder cancer. We assessed the activity of the synthetic retinoid fenretinide in superficial bladder cancer using DNA flow cytometry and conventional cytology as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1ebef32823439da3885928983337d34c
https://publons.com/publon/3631120/
https://publons.com/publon/3631120/
Autor:
Torrisi, R., Boccardo, F., Decensi, A., Stefano Parodi, Fontana, V., Rondanina, G., Formelli, F., Costa, A.
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Administration of the synthetic retinoid Fenretinide lowers circulating retinol and may thus affect night vision. We have recently shown that plasma retinol levels below 100 ng/ml are associated with moderate alterations of the dark adaptometry test.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3a6ea4989511532f7324c21ce96e69fc
http://europepmc.org/abstract/med/8000302
http://europepmc.org/abstract/med/8000302
Autor:
Monica Giordano, Rosalba Torrisi, Elena Collovà, Luigi Celio, Domenico Bilancia, Vincenzo Montesarchio, Valentina Guarneri, Ida Paris, Giuseppina Cilenti, Andrea Sbrana, Sabino De Placido, Alessandra Fabi, Michelino De Laurentiis, Laura Amaducci, Alessio Schirone, Roberta Caputo, Erminio Bonizzoni, Marina Elena Cazzaniga
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background NEPA is an oral fixed-dose combination of netupitant, a new highly selective neurokinin-1 receptor antagonist, and palonosetron. This study was conducted to evaluate whether the efficacy of NEPA against chemotherapy-induced nausea and vomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f5fde6ecff24f41c31581bf75dae17
http://hdl.handle.net/11577/3362400
http://hdl.handle.net/11577/3362400
Autor:
Marco Colleoni, Rosalba Torrisi, Alberto Luini, Vincenzo Bagnardi, Aron Goldhirsch, Nicole Rotmensz, Paolo Veronesi, Anna Cardillo, Giuseppe Viale, Mauro G. Mastropasqua
Publikováno v:
European Journal of Cancer. 46:2216-2224
Background: Tools able to predict pathological complete response (pCR) to preoperative chemotherapy might improve treatment outcome. Patients and methods: Data from 783 patients with invasive ductal carcinoma treated with preoperative chemotherapy an
Autor:
Anna Cardillo, E. Scarano, Angelica Calleri, Patrizia Mancuso, Vincenzo Bagnardi, Rosalba Torrisi, Francesco Bertolini, A. Goldhirsch, Laura Orlando, Marco Colleoni, Alberto Luini, Giuseppe Viale
Publikováno v:
British Journal of Cancer
The antiangiogenic agent bevacizumab showed synergistic effects when combined with chemotherapy in advanced breast cancer. We presently investigated the activity of bevacizumab in combination with chemotherapy, including capecitabine and vinorelbine,
Autor:
Vincenzo Bagnardi, Giuseppe Viale, Paolo Veronesi, Alberto Luini, Luca Bottiglieri, R. Ghisini, A. Goldhirsch, C D'Alessandro, Silvia Dellapasqua, Rosalba Torrisi, Giancarlo Pruneri, Marco Colleoni, Elena Magni
Publikováno v:
British Journal of Cancer
Preoperative endocrine therapy is effective in postmenopausal patients with breast cancers expressing oestrogen receptor. We investigated the activity of primary therapy with letrozole in combination with GnRH analogue in premenopausal women with T2-
Autor:
Eugenio Vanetti, M. Eboli, Rosalba Torrisi, Pietro Mancosu, Antonella Fogliata, Giorgia Nicolini, Filippo Alongi, Alessandro Clivio, Wolfgang Gatzemeier, Carlos A. Garcia-Etienne, Marco Alloisio, Marta Scorsetti, S. Pentimalli, Luca Cozzi, Carlo Rossetti, Armando Santoro, Giovanna Masci, Francesca Lobefalo, Alberto Testori, Stefano Arcangeli, A. Rubino, Pierina Navarria, Andrea Sagona, Corrado Tinterri
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 7, Iss 1, p 145 (2012)
Radiation Oncology, Vol 7, Iss 1, p 145 (2012)
Background To report results in terms of feasibility and early toxicity of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery. Methods Betwe
Autor:
Rosalba Torrisi, Alberto Luini, Paolo Veronesi, Giancarlo Pruneri, Viviana Galimberti, Vincenzo Bagnardi, Emilia Montagna, A. Goldhirsch, Giuseppe Viale, Nicole Rotmensz, Silvia Dellapasqua, Marco Colleoni, Mattia Intra
Background: We aimed to predict disease-free survival (DFS) in patients who failed to achieve a pathologic complete remission (pCR) after preoperative chemotherapy (PC). Patients and methods: Data from 577 patients treated with PC and operated at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a476db28254fe519bb6eef4d0addd3fd
http://hdl.handle.net/10281/12873
http://hdl.handle.net/10281/12873
Autor:
Marco Colleoni, Anna Cardillo, Mattia Intra, Nicole Rotmensz, Rosalba Torrisi, Giuseppe Viale, Vincenzo Bagnardi, Paolo Veronesi, Julia Rodriguez, E. Scarano, Emilia Montagna, A. Goldhirsch, Alberto Luini
Publikováno v:
British Journal of Cancer
Locally advanced breast cancer (LABC) is associated with dire prognosis despite progress in multimodal treatments. We evaluated several clinical and pathological features of patients with either noninflammatory (NIBC, cT4a-c) or inflammatory (IBC, cT